Clinical Benefits of UroVysion® DNA Test Highlighted |
A review of multiple studies in the journal Urology indicates that UroVysion®, a DNA-based urine test that detects key genetic changes in bladder cells, showed favorable clinical attributes not found in other available biomarkers in the detection of bladder cancer.
|
| Ref. URL: http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0318.htm |
Added on : 05 Jun - 02:40 PM |
CLG to attend 2006 ISSCR Conference |
Cell Line Genetics will be attending the 2006 International Society of Stem Cell Research in Toronto, Canada. Meet us at Booth #125 and learn about how CLG can help accelerate and improve the quality of your research.
|
| Ref. URL: http://www.isscr.org/meetings/index.htm |
Added on : 01 Jun - 07:39 PM |
Cell Line Genetics launches Stem Cell Quality Assurance Services |
Cell Line Genetics (CLG), a private venture based in Madison, Wisconsin, has launched a suite of services addressing the growing need for quality assurance in Stem Cell Research.
|
| Ref. URL: http://www.clgenetics.com/stem-cell.php |
Added on : 23 May - 03:42 PM |